BALANCE SHEETS - USD ($)	Dec. 31, 2018	Sep. 30, 2018
CURRENT ASSETS:
Cash and cash equivalents	$ 6,682,205	$ 10,310,044
Receivables	128,762	118,657
Prepaid expenses	433,783	364,622
Inventory used for R&D and manufacturing	682,525	645,238
Total current assets	7,927,275	11,438,561
Plant, property and equipment, net	16,082,143	16,218,851
Patent costs, net	252,882	258,093
Deposits	1,670,917	1,670,917
Total Assets	25,933,217	29,586,422
CURRENT LIABILITIES:
Accounts payable	4,903,189	5,743,913
Accrued expenses	77,710	205,310
Due to employees	896,833	764,941
Derivative instruments, current portion	0	2,498,606
Other current liabilities	13,769	14,029
Total current liabilities	5,891,501	9,226,799
Derivative instruments - net of current portion	3,760,758	6,818,458
Lease Liability	13,414,185	13,379,962
Deferred income	126,795	126,795
Other liabilities	32,126	33,492
Total liabilities	23,225,365	29,585,506
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 27,843,327 and 28,034,487 shares issued and outstanding at December 31, 2018 and September 30, 2018, respectively	278,435	280,346
Additional paid-in capital	332,775,129	331,312,184
Accumulated deficit	(330,345,712)	(331,591,614)
Total stockholders' equity	2,707,852	916
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 25,933,217	$ 29,586,422